RJ Stephens
-
- Lung Cancer Treatments and Mutations 16
- Lung Cancer Diagnosis and Treatment 13
- Oncology top 2%
- Lung Cancer Research Studies 13
- Colorectal Cancer Treatments and Studies 3
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 4
- Radiation top 5%
-
- Neuroendocrine Tumor Research Advances 6
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
-
- Childhood Cancer Survivors' Quality of Life 4
RJ Stephens
43 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Pulmonary and Respiratory Medicine 1.6k
- Oncology 1.2k
- Otorhinolaryngology 160
- Radiation 169
- Radiology, Nuclear Medicine and Imaging 281
Countries citing papers authored by RJ Stephens
This map shows the geographic impact of RJ Stephens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RJ Stephens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RJ Stephens more than expected).
Fields of papers citing papers by RJ Stephens
This network shows the impact of papers produced by RJ Stephens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RJ Stephens. The network helps show where RJ Stephens may publish in the future.
Co-authorship network
The 25 scholars most cited alongside RJ Stephens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials - NSCLC meta-analyses collaborative group | 2008 | 165 |
| 2 | 2006 | 124 | |
| 3 | 2006 | 41 | |
| 4 | 2005 | 4 | |
| 5 | The big lung trial (BLT): Determining the value of cisplatin- based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting | 2002 | 43 |
| 6 | Preliminary results of a multicentre randomised trial comparing 3 chemotherapy regimens (De Gramont, Lokich and Raltitrexed) in metastatic colorectal cancer | 1999 | 41 |
| 7 | 1997 | 18 | |
| 8 | 1997 | 35 | |
| 9 | 1997 | 43 | |
| 10 | 1996 | 125 | |
| 11 | 1995 | 5 | |
| 12 | 1995 | 155 | |
| 13 | 1994 | 1 | |
| 14 | 1993 | 59 | |
| 15 | 1993 | 8 | |
| 16 | 1993 | 34 | |
| 17 | 1993 | 25 | |
| 18 | 1992 | 195 | |
| 19 | 1991 | 10 | |
| 20 | 1977 | 58 |
About RJ Stephens
RJ Stephens is a scholar working on Otorhinolaryngology, Oncology, Hepatology, Pulmonary and Respiratory Medicine and Toxicology, having authored 43 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (13 papers), Lung Cancer Diagnosis and Treatment (13 papers), Neuroendocrine Tumor Research Advances (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Head and Neck Cancer Studies (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.6k citations), Oncology (1.2k citations), Otorhinolaryngology (160 citations), Radiation (169 citations) and Radiology, Nuclear Medicine and Imaging (281 citations). RJ Stephens has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include DJ Girling, David Machin, Penelope Hopwood, NM Bleehen, Lesley Stewart, R L Souhami, Sarah Burdett, Jean‐Pierre Pignon, R. Arriagada and P Rocmans. Their work appears in journals such as British Journal of Cancer, Lung Cancer, European Journal of Cancer, The Lancet and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.